It is uncertain whether or not EPO in brain tissue is altered among depressed patients, although it was reported that this factor was elevated in the CFS (but not in serum) of depressed individuals and that chronic antidepressants reduced CSF EPO levels (Nakamura et al., 1998). This evidence concerns the gene EPO and myalgic encephalomeyelitis/chronic fatigue syndrome.